| ∧ ∨ Type | ∧ ∨ Title | Principal Investigators | Status | ∧ ∨ Year |
|---|---|---|---|---|
| PRIN2020 - PRIN bando 2020 |
Escaping the ESKAPEs: integrated pipelines for new antibacterial drugs
|
|
Ongoing | 2022 |
| PRIN2020 - PRIN bando 2020 |
RE-Plast: targeting functional and structural plasticity in Alzheimer disease. From diagnosis to treatment
|
|
Ongoing | 2022 |
| FON_NAZ - Bandi Altre Fondazioni |
An integrative approach for the systematic characterization of mitochondrial regulators in hepatocellular carcinoma (3° anno)
|
|
Closed | 2022 |
| PSR_LINEA2_ / Piano di sviluppo di ricerca - Dotazioni dipartimentali - Linea 2 |
Piano di Sostegno alla Ricerca 2015-2017 - Linea 2 "Dotazione annuale per attività istituzionali" (anno 2021)
|
|
Ongoing | 2022 |
| Horizon Europe Global Challenge-RIA/IA/CSA |
Next generation advanced RNA inhibition therapy to treat cardiometabolic disease (LiverTarget)
|
|
Ongoing | 2022 |
| CAR_RIC - Bandi Fondazione Cariplo |
Dissecting the role of anti-GluA3 antibodies in Frontotemporal Dementia: from bench to bedside
|
|
Ongoing | 2022 |
| Horizon Europe - Marie Skłodowska-Curie actions - Doctoral Networks (DN) |
Metal-containing Radical Enzymes (MetRaZymes)
|
|
Ongoing | 2022 |
| Progetti PNRR - per il potenziamento di strutture di ricerca e creazioni di campioni nazionali di R&S |
National Center for Gene Therapy and Drugs based on RNA Technology
|
|
Ongoing | 2022 |
| INTLI - Finanziamenti internazionali |
Unveiling neuroplastic mechanisms in a periphery-to- brain crosstalk in an experimental model of anorexia nervosa
|
|
Closed | 2022 |
| H20_RIA - Horizon 2020_Research & Innovation Action/Innovation Action |
The impact of early life stress in later life (EarlyCause)
|
|
Ongoing | 2022 |
